Cancer Gene Therapy
Cancer therapies square measure medicine or different substances that block the growth and unfold of cancer by intrusive with specific molecules (molecular targets) that square measure involved within the growth, progression and unfold of cancer. Many cancer therapies square measure approved by the Food and Drug Administration (FDA) to treat specific styles of cancer. The event of targeted therapies desires the identification of fine targets that is, targets that play a key role in neoplastic cell growth and survival. One approach to distinctive potential targets is to match the amounts of individual proteins in cancer cells with those in traditional cells. Proteins that square measure gift in cancer cells however not traditional cells or that square measure a lot of voluminous in cancer cells would be potential targets, notably if they are famed to worry in cell growth or survival.
RNAI approaches
Drug resistance
Hematopoietic root cell factor transfer
Cellular therapies
Ribozyme technology
Gene delivery systems (viral and non-viral)
DNA synthesis and repair
Related Conference of Cancer Gene Therapy
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Cancer Gene Therapy Conference Speakers
Recommended Sessions
- Immunotherapy
- Biomaterials and Biomechanics
- Biomedical Engineering
- Cancer Cell Biology
- Cancer Gene Therapy
- Cell Medical Care Bioprocessing
- Cell Therapy
- Clinical and Translation Research
- Clinical applications of Stem Cells
- Gene Therapy
- Genetic Medicine
- Medical and Nano Biotechnology
- Stem Cell Therapeutics in Modern Era
- Stem Cells Growth and Regeneration
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
